三优生物 Sanyou Bio
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched 2023-06-12 08:00
Sanyou's STAL helps researchers to explore the forefront of Life Sciences with high-impact literature publication 2023-06-07 20:00
Sanyou launches new European offices and continues to promote global business landscape 2023-06-03 20:05
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation 2022-08-28 08:00
Sanyou Biopharmaceuticals Closed the Series B+ Financing Round of Tens of Millions of RMB Led by Huatai Zijin 2022-08-03 08:00
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application 2022-06-26 08:00
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D 2022-06-25 08:00
Guojun Lang, CEO of Sanyou: New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets 2022-06-11 08:00
Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform Announced - World Premiere 2022-06-03 08:00
Bispecific antibody drug against COVID-19 jointly developed by Shanghai ZJ Bio-Tech and Sanyou Biopharmaceuticals appearing at China International Import Expo (CIIE) 2021-11-22 21:00
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery 2021-06-26 23:00
1 2